A study involving 2,260 adolescents 12 to 15 years old found vaccination led to a higher protective antibody response than in adults, and was 100% effective against symptomatic disease. Of the 16 trial participants infected with COVID-19, none had received the vaccine; all had received the placebo.
"Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available scientific data as we have with all of our COVID-19 vaccine authorizations," Marks said Tuesday.